SCHEMBL8524320

SCHEMBL8524320

c1ccc(Oc2cccc([C@H]3CO3)c2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.57
TAAR1 Q96RJ0 1/20 0.55
MAOB P27338 1/20 0.46
ALOX5 P09917 2/20 0.45
PARP1 P09874 1/20 0.45
LTA4H P09960 1/20 0.44
KCNH2 Q12809 1/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
HTT P42858 2/20 0.44
MEN1 O00255 1/20 0.44
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 1/20 0.44
ALOX15 P16050 1/20 0.44
KMT2A Q03164 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
ADRA1A P35348 2/20 0.43
TEAD1 P28347 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8524892 1.00 TSHR (0.57) TSHRTAAR1MAOBALOX5PARP1
SCHEMBL7039757 0.82 TSHR (0.64) TSHRLTA4HTDP1ADRA1AHTR1A
SCHEMBL8828036 0.82 TSHR (0.64) TSHRLTA4HTDP1ADRA1AHTR1A
SCHEMBL8828040 0.82 TSHR (0.64) TSHRLTA4HTDP1ADRA1AHTR1A
SCHEMBL10824462 0.80 TAAR1 (0.50) TSHRTAAR1MAOBALOX5LTA4H
SCHEMBL7784267 0.79 HTR2C (0.54) TSHRPARP1MEN1LMNAGAA
SCHEMBL936624 0.79 HTR2C (0.54) TSHRPARP1MEN1LMNAGAA
SCHEMBL6493903 0.79 HTR2C (0.54) TSHRPARP1MEN1LMNAGAA
SCHEMBL8190359 0.78 MAOB (0.53) TSHRMAOBALOX5KCNH2KDM1A
SCHEMBL8190357 0.78 MAOB (0.53) TSHRMAOBALOX5KCNH2KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5872117-A TREATING CEREBROVASCULAR DEMENTIA, SENILE DEMENTIA, ALZHEIMER'S DEMENTIA, SEQUELAE OF ISCHEMIC ENCEPHALOPATHY AND CEREBRAL APOPLEXY TOYAMA CHEMICAL CO., LTD. (JP) 1999-02-16 US disclosed
US-5719150-A ALZHEIMER'S DISEASE TOYAMA CHEMICAL CO., LTD. (JP) 1998-02-17 US disclosed
EP-0587194-B1 2-(Heterocycloalkoxy)-1-(subst.-phenyl)-ethanol derivatives as cerebral function improving agents TOYAMA CHEMICAL CO LTD (JP) 1997-06-04 EP disclosed
EP-0587193-B1 1,2-Ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO LTD (JP) 1997-01-02 EP disclosed
US-5472984-A 1,2-ethanediol derivative and salt thereof and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1995-12-05 US disclosed
EP-0589484-A1 1,2-Ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1994-03-30 EP disclosed
EP-0587194-A1 2-(Heterocycloalkoxy)-1-(subst.-phenyl)-ethanol derivatives as cerebral function improving agents TOYAMA CHEMICAL CO., LTD. (JP) 1994-03-16 EP disclosed
EP-0587193-A1 1,2-Ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1994-03-16 EP disclosed
US-5280032-A 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1994-01-18 US disclosed
EP-0383281-A1 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same TOYAMA CHEMICAL CO., LTD. (JP) 1990-08-22 EP disclosed